Pro-proliferative function of the long isoform of PML-RARα involved in acute promyelocytic leukemia

Oncogene

Volumn 25, Issue 24, 2006, Pages 3375-3386

  Tussie Luna M I ^a   Rozo, L ^a   Roy, A L ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

APL; c fos; Chromatin; PML RAR ; Transcription

Indexed keywords

HYBRID PROTEIN; ISOPROTEIN; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL GROWTH; CELL PROLIFERATION; CHROMOSOME; GENE ACTIVATION; GENE FUSION; MITOGENESIS; NONHUMAN; ONCOGENE; ONCOGENE C FOS; PRIORITY JOURNAL; PROMOTER REGION; PROMYELOCYTIC LEUKEMIA; PROMYELOCYTIC LEUKEMIA RETINOIC ACID RECEPTOR ALPHA GENE; PROTEIN FUNCTION; TRANSCRIPTION INITIATION;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CERCOPITHECUS AETHIOPS; COS CELLS; HISTONE DEACETYLASES; LEUKEMIA, PROMYELOCYTIC, ACUTE; MICE; NEOPLASM PROTEINS; NIH 3T3 CELLS; ONCOGENE PROTEINS, FUSION; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-FOS; TRETINOIN;

EID: 33745033595     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209388     Document Type: Article

References (54)

1. Alberts AS, Geneste O, Treisman R. (1998). Cell 92: 475-487.
2. Alcalay M, Meani N, Gelmetti V, Fantozzi A, Fagioli M, Orleth A et al. (2003). JCI 112: 1751-1761.
3. Altucci L, Gronemeyer H. (2001). Nat Rev 1: 181-193.
4. Casini T, Pelicci PG. (1999). Oncogene 18: 3235-3243.
5. Codina A, Love JD, Li Y, Lazar MA, Neuhaus D, Schwabe WR. (2005). Proc Natl Acad Sci USA 102: 6009-6014.
6. Cress WD, Seto E. (2000). J Cell Physiol 184: 1-16.
7. de The H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A. (1991). Cell 66: 675-684.
8. Di Croce L, Raker VA, Corsaro M, Fazi F, Fanelli M, Faretta M et al. (2002). Science 295: 1079-1082.
9. Doucas V, Brockes J, Yaniv M, deThé H, Dejean A. (1993). Proc Natl Acad Sci USA 90: 9345-9349.
10. Duprez E. (2004). Cell Cycle 3: 389-390.
11. Duprez E, Wagner K, Koch H, Tenen DG. (2003). EMBO J 22: 5806-5816.
12. Ferrucci PF, Grignani F, Pearson M, Fagioli M, Nicoletti I, Pelicci PG. (1997). Proc Natl Acad Sci USA 94: 10901-10906.
13. Goddard AD, Borrow J, Freemont PS, Solomon E. (1991). Science 254: 1371-1374.
14. Grignani F, De Matteis S, Nervi C, Tomassoni L, Gelmetti V, Cioce M et al. (1998). Nature 391: 815-818.
15. Grignani F, Ferrucci PF, Testa U, Talamo G, Fagioli M, Alcalay M et al. (1993). Cell 74: 423-431.
16. Guo A, Salomoni P, Luo J, Shih A, Zhong S, Gu W et al. (2000). Cell Biol 2: 730-736.
17. Hake SB, Xiao A, Allis CD. (2004). Br J Cancer 90: 761-769.
18. Hartman HB, Yu J, Alenghat T, Ishizuka T, Lazar MA. (2005). EMBO Rep 6: 445-451.
19. Hauksdottir H, Privalsky ML. (2001). Cell Growth Differ 12: 85-98.
20. Hazzalin CA, Mahadevan LC. (2002). Nat Rev 31: 30-40.
21. Insinga A, Monestiroli S, Ronzoni S, Carbone R, Pearson M, Pruneri G et al. (2004). EMBO J 10: 1144-1154.
22. Insinga A, Pelicci PG, Minucci S. (2005). Cell Cycle 4: 67-69.
23. Jurcic JC, Nimer SD, Scheinberg DA, DeBlasio T, Warrell Jr RP, Miller Jr WH. (2001). Blood 98: 2651-2656.
24. Kane JR, Head DR, Balaz L, Hulshof MG, Motroni TA, Raimondi SC et al. (1996). Leukemia 10: 1296-1302.
25. Khan MM, Nomura T, Kim H, Kaul SC, Wadhwa R, Shinagawa T et al. (2001). Mol Cell 7: 1233-1243.
26. Kim DW, Cheriyath V, Roy AL, Cochran BH. (1998). Mol Cell Biol 18: 3310-3320.
27. Lallemand-Breitenbach V, Zhu J, Puvion F, Koken M, Honore N, Doubeikovsky A et al. (2001). J Exp Med 193: 1361-1372.
28. Li QJ, Yang SH, Maeda Y, Sladek FM, Sharrocks AD, Martins-Green M.. (2003). EMBO J 22: 281-291.
29. Lin R, Evans R. (2000). Mol Cell 5: 821-830.
30. Lin RJ, Nagy L, Inoue S, Shao W, Miller Jr WH, Evans RM. (1998). Nature 391: 811-814.
31. Lunghi P, Tabilio A, Lo-Coco F, Pelicci P, Bonati A. (2005). Leukemia 19: 234-244.
32. Marmorstein R. (2001). Nat Rev 2: 422-432.
33. Meani N, Minardi S, Licciulli S, Gelmetti V, Coco FL, Nervi C et al. (2005). Oncogene 24: 3358-3368.
34. Minucci S, Maccarana M, Cioce M, De Luca P, Gelmetti V, Segalla S et al. (2000). Mol Cell 5: 811-820.
35. Müller C, Yang R, Park DJ, Serve H, Berdel WE, Koeffler P. (2000). Blood 96: 3894-3899.
36. Narlikar GJ, Fan HY, Kingston RE. (2002). Cell 108: 475-487.
37. Nissen LJ, Gelly JC, Hipskind RA. (2001). J Biol Chem 276: 5213-5221.
38. Nouzova M, Holtan N, Oshiro MM, Isett RB, Munoz-Rodriguez JL, List AF et al. (2004). J Pharmacol Exp Ther 311: 968-981.
39. Pandolfi PP. (2001). Hum Mol Gen 10: 769-775.
40. Pandolfi PP, Alcalay M, Fagioli M, Zangrilli D, Mencarelli A, Diverio D et al. (1992). EMBO J 11: 1397-1407.
41. Park DJ, Vuong PT, de Vos S, Douer D, Koeffler HP. (2003). Blood 102: 3727-3736.
42. Quignon F, De Bels F, Koken M, Feunteun J, Ameisen JC, de Thé H. (1998). Nat Genet 20: 259-265.
43. Salomoni P, Pandolfi PP. (2002). Cell 108: 165-170.
44. Segalla S, Rinaldi L, Kilstrup-Nielsen C, Badaracco G, Minucci S, Pelicci PG et al. (2003). Mol Cell Biol 23: 8795-8808.
45. Soprano DR, Qin P, Soprano KJ. (2004). Annu Rev Nutr 24: 201-221.
46. Sucic M, Zadro R, Burazer B, Labar B, Nemet D, Mrsic M et al. (2002). J Hematother Stem Cell Res 11: 941-950.
47. Thomson S, Clayton AL, Mahadevan LC. (2001). Mol Cell 8: 1231-1241.
48. Wang ZG, Delva L, Gaboli M, Rivi R, Giorgio M, Cordon-Cardo C et al. (1998a). Science 279: 1547-1551.
49. Wang ZG, Ruggero D, Ronchetti S, Zhong S, Gaboli M, Rivi R et al. (1998b). Nat Genet 20: 266-272.
50. Zelent A, Guidez F, Melnick A, Waxman S, Licht JD. (2001). Oncogene 20: 7186-7203.
51. Zhong S, Muller S, Freemont PS, Dejeann A, Pandolfi PP. (2000a). Blood 95: 2748-2753.
52. Zhong S, Salomoni P, Pandolfi PP. (2000b). Nat Cell Biol 2: E85-E90.
53. Zhu J, Gianni M, Kopf E, Honore N, Chelbi-Alix M, Koken M et al. (1999). Proc Natl Acad Sci USA 96: 14807-14812.
54. Zhu J, Lalleman-Breitenbach V, de Thé H. (2001). Oncogene 20: 7257-7265.